Location History:
- Paris, FR (2016 - 2017)
- Lyons, FR (2022)
Company Filing History:
3 out of 1,743 
3 out of 99 
2 out of 2 
Years Active: 2016-2022
Title: Marion Darnaud: Innovator in Microbiota Protection
Introduction
Marion Darnaud is a notable inventor based in Paris, France, recognized for his contributions to the field of microbiota protection. With a total of three patents, his work focuses on innovative solutions for health-related issues, particularly concerning oxygen-sensitive gram-positive bacteria.
Latest Patents
Darnaud's latest patents include a Reg3α polypeptide designed for the protection of oxygen-sensitive gram-positive bacteria. This invention demonstrates significant advancements in understanding the gut microbiota's composition and its impact on host resistance to intestinal inflammation. The polypeptide has shown potent antioxidant activity on intestinal epithelial cells during colitis, promoting the survival of highly oxygen-sensitive bacteria. Additionally, his work includes a composition involving the HIP/PAP protein aimed at treating insulin resistance in non-insulin-dependent subjects.
Career Highlights
Throughout his career, Marion Darnaud has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Alfact Innovation. His research has contributed to significant advancements in the understanding of microbiota-related diseases and disorders.
Collaborations
Darnaud has collaborated with notable individuals in his field, including Christian Brechot and Jamila Faivre, who have contributed to his research endeavors.
Conclusion
Marion Darnaud's innovative work in microbiota protection and his contributions to health science highlight the importance of research in developing effective treatments for various gastrointestinal disorders. His patents reflect a commitment to advancing medical knowledge and improving patient outcomes.